Long-term efficacy and safety of sodium-glucose cotransporter-2 inhibitors as add-on to metformin treatment in the management of type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Long-term efficacy and safety of sodium-glucose cotransporter-2 inhibitors as add-on to metformin treatment in the management of type 2 diabetes mellitus

Published:2017-07 Issue:27 Volume:96 Page:e7201
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Li Jian,Gong Yanping,Li Chunlin,Lu Yanhui,Liu Yu,Shao Yinghong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference37 articles.

1. Development and potential role of type-2 sodium-glucose transporter inhibitors for management of type 2 diabetes;Hardman;Diabetes Ther,2011

2. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?;Chawla;Indian J Endorinol Metab,2016

3. New combination treatments in the management of diabetes: focus on sitagliptin-metformin;Green;Vasc Health Risk Manage,2008

4. Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes;Scheen;Diabetes Metab,2013

5. Approaches to glycemic treatment.;Diabetes Care,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of lower extremity amputation in patients with type 2 diabetes mellitus and peripheral arterial disease receiving sodium‐glucose cotransporter‐2 inhibitors versus other medications: A systematic review and meta‐analysis of observational cohort studies;Diabetes, Obesity and Metabolism;2024-04

2. Comparative Effectiveness of Antidiabetic Drugs as an Additional Therapy to Metformin in Women with Polycystic Ovary Syndrome: A Systematic Review of Metabolic Approaches;International Journal of Endocrinology;2024-03-11

3. Oral Glucose‐Lowering Agents;Textbook of Diabetes;2024-01-12

4. Effects of SGLT2 inhibitors on cardiac function and health status in chronic heart failure: a systematic review and meta-analysis;Cardiovascular Diabetology;2024-01-03

5. A Comparison of Efficacy among Syrian diabetic patients treated with Empagliflozin versus Dapagliflozin, a Randomized, Triple-blind, Two-period crossover study;Research Journal of Pharmacy and Technology;2023-10-31